EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.17.21 | Abortion, Spontaneous |
22310383 |
Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility. |
causal interaction
diagnostic usage
unassigned |
4
2
0 |
| 3.4.17.21 | Acquired Immunodeficiency Syndrome |
19995130 |
GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.4.17.21 | Adenocarcinoma |
7491049 |
Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
4
2
0 |
| 3.4.17.21 | Adenocarcinoma |
7497608 |
Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. |
diagnostic usage
ongoing research
unassigned |
4
3
0 |
| 3.4.17.21 | Adenocarcinoma |
9215402 |
Prostate-specific membrane antigen. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
4
1 |
| 3.4.17.21 | Adenocarcinoma |
9610707 |
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. |
causal interaction
ongoing research
unassigned |
1
2
0 |
| 3.4.17.21 | Adenocarcinoma |
9694964 |
Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
2
2
0 |
| 3.4.17.21 | Adenocarcinoma |
9763084 |
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. |
causal interaction
diagnostic usage
unassigned |
3
3
0 |
| 3.4.17.21 | Adenocarcinoma |
9843660 |
The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
2
1
0 |
| 3.4.17.21 | Adenocarcinoma |
10412041 |
Cloning and characterization of the prostate-specific membrane antigen promoter. |
causal interaction
diagnostic usage
unassigned |
3
2
0 |
